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Abstract
Background: Coxsackie B is a viral pathogen that presents with various invasive diseases in adults. Historically, the
majority of adult cases with pericarditis or myocarditis have been attributed to coxsackievirus B. The presentation of
this viral infection causing effusive-constrictive pericarditis, hepatitis or pancreatitis is rare. This case report is the first
to describe a patient with concomitant effusive-constrictive pericarditis, hepatitis and pancreatitis from possible
coxsackievirus B infection.
Case presentation: A 26-year old female was admitted to our hospital with the diagnosis of effusive-constrictive
pericarditis complicated by tamponade and cardiac arrest. An emergent pericardiocentesis was performed
successfully. Hepatitis and pancreatitis were also identified in our patient. After an extensive workup, coxsackievirus
B infection was suspected by positive serum complement fixation antibody titers. Our patient made a full recovery
and was discharged from the hospital.
Conclusion: Clinical suspicion of effusive-constrictive pericarditis with tamponade from coxsackievirus B should be
considered in patients presenting with chest pain, dyspnea, jugular venous distention, hypotension, ST segment
elevation on electrocardiogram, and ventricular interdependence with septal shift during diastole on transthoracic
echocardiogram. Initial diagnoses of effusive-constrictive pericarditis resembling cardiac tamponade, hepatitis and
pancreatitis can be challenging, and this case highlights the need for healthcare professionals to be cognizant of
the association between these unusual clinical presentations and coxsackievirus B infection.
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Background
Coxsackievirus, a RNA Enterovirus, has been tradition-
ally associated with a number of clinical diseases in chil-
dren and adults. The species is divided into two groups
and 29 serotypes [1]. Coxsackie group A viruses can
cause aseptic meningitis in adults, and commonly infect
skin and mucous membranes in herpangina, conjunctiv-
itis and hand, foot and mouth disease in children [1].
Group B viruses cause herpangina, pleurodynia, and in-
fect the heart, pancreas, and liver which can give rise to
myocarditis, pericarditis, pancreatitis and hepatitis in
adults [2]. Viral pericarditis is inflammation of the peri-
cardium or the lining surrounding the heart that is
caused by viral infections [2]. Coxsackie B viruses are
the most common cause of myocarditis and pericarditis
in adults and have been identified in up to 50 % of viral
cardiac cases [3–5]. A number of other viral, bacterial,
and fungal infections as well as medications has also
been shown to cause myocarditis and pericarditis [2, 6].
However, the presentation of this viral infection is rare
among patients with isolated pancreatitis or hepatitis
[7–11]. Up to 60 % of patients with acute pericarditis
will develop a small pericardial effusion [6]. Notably,
viral pericarditis can lead to pericardial constriction as a
late complication [12, 13]. Constrictive pericarditis with
effusion has been detected in ten percent of patients
with clinical tamponade [2]. Coxsackie B viruses usually
cause various single organ system diseases, but the com-
bination of myocarditis, pancreatitis and hepatitis has
been documented in two case reports [14, 15]. Herein,
* Correspondence: j.persichino@ruhealth.org
1Department of Internal Medicine, Riverside University Health System
Medical Center, 26520 Cactus Avenue, Moreno Valley, CA 92555, USA
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Persichino et al. BMC Infectious Diseases  (2016) 16:375 
DOI 10.1186/s12879-016-1752-3
we report a case of possible coxsackievirus B infection
causing effusive-constrictive pericarditis, hepatitis and
pancreatitis.
Case presentation
A 26-year old Latina female sought medical attention at
our emergency department with progressive throat pain
and chest pain for 1 week. She then developed fevers,
dizziness, shortness of breath, and abdominal pain with
nausea and vomiting 2 days prior to admission. She did
not seek prior medical attention and used over-the-
counter ibuprofen for the fevers. The patient denied any
recent travel, unusual food consumption or animal
exposures.
Further history revealed that the patient’s 10-year old
sister was recovering from an upper respiratory infection
with fevers, throat pain, cough and shortness of breath
for 1 week. Past medical history was significant for con-
genital adrenal hyperplasia. Our patient denied current
usage of tobacco, alcohol, or intravenous drugs. She had
no known drug allergies and had been taking physiologic
doses of hydrocortisone 30 milligrams (mg) per day and
fludrocortisone 0.5 mg per day for her congenital ad-
renal hyperplasia. The patient disclosed to the medical
team that she had run out of her hydrocortisone and flu-
drocortisone approximately 4 to 6 weeks prior to
admission.
Initial vital signs in the emergency department demon-
strated a temperature of 102.0 °F (38.9 °C), heart rate of
102 per minute, respiratory rate of 28 per minute, oxy-
gen saturation of 95 % while breathing 6 liters of oxygen
per minute via face mask, and blood pressure of 50/21
millimeters of mercury. On examination, she was ill
appearing and diaphoretic. There was jugular venous
distention by visualization of the neck veins and distant
heart sounds upon auscultation. Aggressive intravenous
fluid hydration, vasopressor medications, and intraven-
ous hydrocortisone were initiated for suspected septic
shock and adrenal crisis. Supplemental oxygen was
provided by face mask. Empiric antibiotic treatments
with vancomycin, levofloxacin, fluconazole, and metro-
nidazole were initiated based upon consultation with the
infectious diseases specialist. Blood and urine cultures
were collected in the emergency department before anti-
biotic administration. Pertinent laboratory findings in
our patient on admission and during hospitalization are
shown on Table 1. A 12-lead electrocardiogram (ECG)
showed 1–2 mm ST segment elevations in precordial
V2-V6 leads as shown in Fig. 1. Pericarditis with tam-
ponade was suspected by the emergency room
personnel. An emergent bedside transthoracic echocar-
diogram (TTE) was performed by a technician which re-
vealed a small pericardial effusion. A portable chest
radiograph was remarkable for vascular congestion only.
Two hours after her arrival to the emergency depart-
ment, the patient developed cardiac arrest. Adult cardiac
life support was initiated in which intubation and cardio-
pulmonary resuscitation were performed. Intravenous
epinephrine was given for pulseless electrical activity.
Pulse was restored after three minutes of treatment. An
emergent bedside pericardiocentesis with drain place-
ment was carried out by the on-call cardiologist. Three-
hundred milliliters of serosanginous pericardial fluid
were extracted. A repeat bedside TTE revealed minimal
residual effusion of the pericardium with normal ven-
tricular function. The patient was admitted to the inten-
sive care unit with the diagnosis of effusive-constrictive
pericarditis complicated by tamponade, cardiac arrest
and adrenal crisis.
Additional samples of blood and urine were collected
for screening of bacterial (Streptococcus, Staphylococcus,
Meningococcus, Haemophilus, Legionella), fungal (Histo-
plasma, Aspergillus, Candida, Cryptococcus, Coccidio-
mycosis), viral (herpesviruses, human immunodeficiency
virus, Epstein-Barr virus, hepatitis A, B, and C, Cyto-
megalovirus), and mycobacterial (Mycobacterium tuber-
culosis, Mycobacterium avium complex) infections with
negative results. Serological paired complement fixation
Table 1 Laboratory values in our patient on admission, during hospitalization, and post-hospital follow-up
Normal value Day 1 Day 4 Day 8 Day 12 Day 16 Follow-up
After 4 weeks
TB 0.2–1.0 mg/dl 2.3 1.4 0.6 0.4 0.4 0.6
ALT 12–78 U/L 109 868 420 138 86 34
AST 15–37 U/L 213 1,060 189 21 22 29
CK 26–192 U/L 225 353 521 NR NR NR
CKMB 0.5–3.6 ng/ml 3.4 8.4 14.0 NR NR NR
Troponin 0.000–0.045 ng/ml 0.44 0.89 0.45 NR NR NR
Amylase 25–115 U/ml 102 212 NR NR NR NR
Lipase 73–393 U/L 773 1,739 7,880 4,850 NR 262
TB total bilirubin, mg milligrams, dl deciliter, ALT alanine aminotransferase, U units, L liter, AST aspartate transaminase, CK creatinine kinase, CKMB creatinine kinase
MB, ng nanograms, ml milliliter, NR no result
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antibody titers for coxsackie A and B were sent on days
1 and 7 of hospitalization. A panel of serological tests
for rheumatologic, autoimmune and malignant dis-
eases were performed as well. All pericardial fluid
stains and cultures were negative for bacterial, fungal
and mycobacterial diseases. Rheumatologic, auto-
immune and malignancy workups were negative. Our
infectious disease specialist suspected coxsackievirus
infection given patient’s presentation and history of
recent sick contact with her younger sister. Coxsackie
titer antibodies were negative for group A serotypes
A2, A4, A7, A9, A10 and A16. Coxsackie B titer anti-
bodies on day 1 were: B1 (<1:8), B2 (1:16), B3 (1:8),
B4 (<1:8), B5 (1:16), and B6 (1:16). Coxsackie B titers
on day 7 of hospitalization were: B1 (1:8), B2 (1:16),
B3 (1:8), B4 (1:8), B5 (1:16), and B6 (1:16). Real-time
polymerase chain reaction (PCR) of pericardial fluid
for enteroviruses was sent on admission but our out-
side reference laboratory did not have the capability
in performing the test. Viruses were not isolated on
the viral culture of the pericardial fluid. With contin-
ued supportive medical care for the complications fol-
lowing suspected coxsackievirus B infection, our
patient made a full recovery after 17 days in the hos-
pital. Five months after her hospitalization, a repeat
TTE showed normal left ventricular function and
pericardium in our patient.
Discussion
To the best of our knowledge, this is the only case re-
port of a patient with concomitant effusive-constrictive
pericarditis, hepatitis and pancreatitis described in the
medical literature. Coxsackie B 1, 2, and 6 group sero-
types can be associated with complicated disease with
left ventricular dysfunction and myocardial infarction
from myopericarditis and acute liver failure from hepa-
titis [4, 5, 15]. Diagnosis is largely based on clinical man-
ifestations of disease with positive serological tests. In
the acute setting of her rising, positive antibody titers
and clinical presentation of disease, we believe that our
patient acquired coxsackievirus B from her sick, younger
sister. Serological markers for coxsackie B virus have
been associated with the development of myocarditis
and pericarditis [5]. The combination of myocarditis,
hepatitis and pancreatitis due to coxsackie B infection is
very rare. Two such reported cases were attributed to
coxsackie A4 and B2 serotypes [14, 15]. The disease
process of acute pericarditis can progress to a large peri-
cardial effusion that can cause cardiac tamponade. Our
case differed from classic cardiac tamponade in that
there was not a large pericardial effusion but a stiff peri-
cardium. Only one of the prior published cases reported
a presentation of isolated effusive-constrictive pericardi-
tis by coxsackie A4 and B3 [13]. There are few case re-
ports on hepatitis associated with coxsackie virus
Fig. 1 Electrocardiogram from patient with ST-segment elevations (arrows) in V2-V4 precordial leads
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infection [5, 7, 8]. In a retrospective study of 602 pa-
tients with acute pancreatitis, 22.1 % of cases were prob-
ably attributed to coxsackie viral infection [11]. In a
separate study, only 4.3 % of patients with acute pan-
creatitis exhibited significant rising antibody titers to
coxsackie B virus [11]. The combination of myocarditis
and pancreatitis from coxsackievirus is few and far be-
tween given that the rate of asymptomatic pancreatitis
may be higher than previously thought in infected pa-
tients with myocardial involvement [14].
Acute pericarditis is a rare phenomenon that accounts
for only 0.2 % of all hospital cardiovascular admissions
[6]. Approximately 80–90 % of pericarditis cases in
North America and Western Europe are presumed to be
caused by enteroviruses, herpesviruses, and adenoviruses
[6]. Diagnosis of acute pericarditis can be confirmed by
chest pain that worsens in the recumbent position, a
friction rub upon auscultation, and diffuse ST segment
elevation on the ECG. These characteristic changes on
the ECG can be seen in approximately 50 % of patients
with acute pericarditis [2]. Sixty percent of cases with
acute pericarditis also present with a small pericardial ef-
fusion [6].
Rarely, acute pericarditis can give rise to a large peri-
cardial effusion that can cause tamponade. Reduced
QRS voltage and electrical alternans can be displayed on
the ECG with a large pericardial effusion. Cardiac tam-
ponade presents with dyspnea, jugular venous distention
and hypotension. Jugular venous distension is the most
common physical finding in acute cardiac tamponade
[2]. Cardiac tamponade decreases ventricular diastolic
filling which results in reduction of stroke volume
and cardiac output. The most useful tool for the diag-
nosis of pericarditis and pericardial effusion is the
TTE. Pericardiocentesis is the treatment of choice for
patients presenting with cardiac tamponade. Viruses
are rarely isolated from pericardial fluid after peri-
cardiocentesis [2]. Pericardiotomy with biopsy and
drainage produce the greatest diagnostic yield for
viral identification [2]. In patients with persistent con-
striction after pericardiocentesis, extensive pericar-
diectomy is recommended [12].
Acute pericarditis can also lead to constriction as a late
complication [2]. Effusive-constrictive pericarditis accounts
for 10–20 % of patients with clinical tamponade by redu-
cing ventricular diastolic filling due to a stiff pericardium
[2, 12]. It is an uncommon syndrome that may be missed
in some patients who present with tamponade. A large pro-
spective case review revealed that concomitant constriction
with tamponade was recognized in only 7 out of 1,184 pa-
tients [12]. As illustrated in Fig. 2 and Additional file 1, the
initial TTE of our patient demonstrated a small pericardial
effusion with ventricular interdependence for diastolic fill-
ing and septal bounce. This unique and rare occurrence on
TTE is highly indicative of effusive-constrictive pericarditis
with cardiac tamponade.
Pericarditis and myocarditis may coexist in up to 30 %
of infectious and non-infectious cases [6]. Most cases of
viral myocarditis are caused by coxsackie B serotypes
[14]. Myocarditis can markedly increase troponin levels
in the serum. There was no evidence to suggest that our
patient had myocarditis. The small rise of troponin levels
in her serum was believed to have been caused by de-
mand ischemia from reduced cardiac output due to tam-
ponade as well as cardiopulmonary resuscitation and
reduced clearance from acute renal failure.
The most effective treatment for viral pericarditis is
nonsteroidal anti-inflammatory drugs (NSAIDs) [2, 6].
Colchicine can be used in combination with NSAIDs to
further decrease recurrence rates [2, 6]. The use of low
dose corticosteroids can also be used for treatment and
to lower the recurrence rate in patients who do not re-
spond, are intolerant, or have contraindications to
NSAIDs and colchicine [2, 6]. We did not treat our
Fig. 2 Parasternal short axis still frames of echocardiogram from
patient demonstrating small pericardial effusion (red arrows) with
ventricular interdependence for diastolic filling as evidenced by a
septal shift to the left during right ventricular filling (upper panel, white
arrow) and septal shift to the right during left ventricular filling (lower
panel, white arrow). In the setting of shock and pericardial effusion,
septal bounce is pathognomonic for effusive-constrictive pericarditis
with cardiac tamponade
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patient with NSAIDs and colchicine due to acute renal
failure and possible increased gastrointestinal intolerance
if used together with her stress doses of corticosteroids.
Our case report has several limitations. First, our pa-
tient’s complement fixation antibody titers for coxsackie B
were not significantly elevated during the early course of
infection. We believe that titers of 1:8 to 1:16 may be indi-
cative, but not confirmative, of recent infection. There is
also considerable cross-reactivity between antibody titers
among other enteroviruses. Second, since titer levels per-
sist for a few months, we did not send a convalescent spe-
cimen to determine if there was a significant rise in titers
to confirm our diagnosis. Third, we were unable to con-
firm coxsackie B infection by PCR detection. This case re-
port can highlight the importance for all outside reference
laboratories to obtain the capability in performing real-
time PCR of pericardial fluid specimens for enteroviruses.
In our patient, based on her clinical presentation of peri-
cardial, hepatic, and pancreatic disease with rising, posi-
tive antibody titers, we believe that coxsackievirus B
infection was the likely cause.
Conclusions
This case report describes a rare presentation of possible
coxsackievirus B infection causing sequential effusive-
constrictive pericarditis, hepatitis, and pancreatitis in a
patient following recent exposure. Medical professionals
need to be aware that coxsackievirus B can lead to
effusive-constrictive pericarditis resulting in the develop-
ment of cardiac tamponade and cardiac arrest if left un-
treated. This case illustrates that rapid accumulation of a
small amount of pericardial fluid can result in tampon-
ade physiology. Clinical suspicion of effusive-constrictive
pericarditis should be considered in patients presenting
with chest pain, jugular venous distention, ST segment
elevation on the ECG, hypotension and small pericardial
effusion on TTE. Particularly in patients with signs and
symptoms of tamponade, clinicians should be vigilant in
initiating emergent treatment with pericardiocentesis.
With better awareness and early diagnostic and invasive
interventions, clinicians can make a substantial differ-
ence in the care of their patients with complications
from coxsackievirus B infection.
Additional file
Additional file 1: Echocardiogram of patient showing small pericardial
effusion with ventricular interdependence for diastolic filling as
evidenced by septal bounce due to effusive-constrictive pericarditis and
cardiac tamponade. (MOV 158 kb)
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